Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dilair F Baban"'
Autor:
Vicky Nicolaidou, Mei Mei Wong, Andia N Redpath, Adel Ersek, Dilair F Baban, Lynn M Williams, Andrew P Cope, Nicole J Horwood
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e39871 (2012)
A major therapeutic challenge is how to replace bone once it is lost. Bone loss is a characteristic of chronic inflammatory and degenerative diseases such as rheumatoid arthritis and osteoporosis. Cells and cytokines of the immune system are known to
Externí odkaz:
https://doaj.org/article/1b5a05d299a44e68b10c51f7847f5b30
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e16152 (2011)
MicroRNAs are small non-coding RNA molecules that regulate mRNA translation and stability by binding to complementary sequences usually within the 3' un-translated region (UTR). We have previously shown that the hepatic toxicity caused by wild-type A
Externí odkaz:
https://doaj.org/article/31b27a319ae14a5fb78d650d87af5e7b
Autor:
Emma E. Carter, Nicholas D. Mazarakis, Fiona Margaret Ellard, Anna L. Olsen, Robert D. Barber, Karen L. O'Malley, Dilair F. Baban, Alan J. Kingsman, Jonathan Rohll, Kyriacos Mitrophanous, Mimoun Azzouz, Fraser J. Wilkes, Susan Mary Kingsman
Publikováno v:
Human Molecular Genetics. 10:2109-2121
In this report it is demonstrated for the first time that rabies-G envelope of the rabies virus is sufficient to confer retrograde axonal transport to a heterologous virus/vector. After delivery of rabies-G pseudotyped equine infectious anaemia virus
Autor:
Susan M. Kingsman, Julia A. Sutton, Margaret Esapa, Toby Price, Dilair F. Baban, Jason Slingsby, Alan J. Kingsman, Andrew Slade
Publikováno v:
Human Gene Therapy. 11:1439-1451
A number of stable producer cell lines for high-titer Mo-MuLV vectors have been constructed. Development has previously centered on increasing end-point titers by producing maximal levels of Mo-MuLV Gag/Pol, envelope glycoproteins, and retroviral RNA
Autor:
Leonard W. Seymour, Dilair F Baban
Publikováno v:
Advanced drug delivery reviews. 34(1)
Several model tumour systems are now known to display increased vascular permeability compared with normal tissues, permitting their selective targeting using macromolecular drugs. Preliminary clinical observations suggest that this pathology may be
Publikováno v:
International Journal of Oncology.
Vascular endothelial growth factor (VEGF) Flays a central role in solid tumour angiogenesis, although its expression has never been previously documented in circulating lymphoma or leukaemia cells. Here we have quantified mRNA encoding VEGF isoforms
Autor:
David J. Kerr, Dilair F Baban, Helena M. Earl, Mahmood A. Shoaibi, Leonard W. Seymour, Bo Liu, A. Fabra
Publikováno v:
Biochemical and biophysical research communications. 217(3)
Tumour-secreted vascular endothelial growth factor (VEGF) exerts a number of effects which are important in tumour pathology, including stimulation of angiogenesis and permeabilisation of tumour-associated vasculature. In this study we have examined
Autor:
Nicholas D. Mazarakis, Robert D. Barber, Mimoun Azzouz, F. Wikes, Jonathan Rohll, Fiona Margaret Ellard, Enca Martin-Rendon, Susan Mary Kingsman, Kyriacos Mitrophanous, Dilair F. Baban
Publikováno v:
European Journal of Cancer. 37:S147